News

Filter

Current filters:

NerventraNeurological

1 to 9 of 96128 results

Endo offers to buy Auxilium Pharmaceuticals for $2.2 billion

Endo offers to buy Auxilium Pharmaceuticals for $2.2 billion

17-09-2014

Ireland-domiciled pain drugmaker Endo International has delivered an unsolicited proposal to acquire…

Auxilium PharmaceuticalsEndo InternationalMergers & AcquisitionsNeurologicalPharmaceuticalQLTWomen's HealthXiaflex

Indian pharma envisages exports expansion, including in Latin American

Indian pharma envisages exports expansion, including in Latin American

16-09-2014

India Brand Equity Foundation (IBEF) today announced the sustained collective efforts being made by the…

FinancialGenericsIndiaMarkets & MarketingPatentsSouth America

FDA grants Breakthrough status for Eylea in diabetic retinopathy in patients with DME

FDA grants Breakthrough status for Eylea in diabetic retinopathy in patients with DME

16-09-2014

US biotech firm Regeneron Pharmaceuticals says that the US Food and Drug Administration has granted Eylea…

BayerBiotechnologyEyleaOphthalmicsRegeneron PharmaceuticalsRegulationUSA

Novo Nordisk’s Tresiba shows long-term efficacy and safety in diabetic children and adolescents

Novo Nordisk’s Tresiba shows long-term efficacy and safety in diabetic children and adolescents

16-09-2014

Danish diabetes care giant Novo Nordisk announced positive new data from the BEGIN YOUNG 1 trial today,…

DiabetesNovo NordiskPharmaceuticalResearchTresiba

SIGA Technologies files for Chapter 11 reorganization

SIGA Technologies files for Chapter 11 reorganization

16-09-2014

Biological warfare defense firm SIGA Technologies has filed a voluntary petition for relief under chapter…

Anti-viralsBiotechnologyFinancialLegalPharmAtheneSIGA TechnologiesTecovirimatUSA

Nicox acquires ophthalmic company Doliage and Carragelose eyedrops from Marinomed

Nicox acquires ophthalmic company Doliage and Carragelose eyedrops from Marinomed

16-09-2014

French ophthalmic company Nicox has advanced its strategy of building an international business by acquiring…

CarrageloseEuropeMarinomed BiotechnologiesMergers & AcquisitionsNicOxOphthalmicsPharmaceutical

Merck’s odanacatib succeeds in Ph III osteoporosis trial

Merck’s odanacatib succeeds in Ph III osteoporosis trial

16-09-2014

US pharma giant Merck & Co has announced positive data from the pivotal Phase III fracture outcomes study…

Anti-Arthritics/RheumaticsMerck & CoodanacatibPharmaceuticalResearchWomen's Health

1 to 9 of 96128 results

Back to top